MetLife Ev To Sales vs Dividend Yield Analysis

MET Stock

USD 87.00 0.36 0.42%

MetLife financial indicator trend analysis is infinitely more than just investigating MetLife recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MetLife is a good investment. Please check the relationship between MetLife Ev To Sales and its Dividend Yield accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.

Ev To Sales vs Dividend Yield

Ev To Sales vs Dividend Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MetLife Ev To Sales account and Dividend Yield. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between MetLife's Ev To Sales and Dividend Yield is 0.42. Overlapping area represents the amount of variation of Ev To Sales that can explain the historical movement of Dividend Yield in the same time period over historical financial statements of MetLife, assuming nothing else is changed. The correlation between historical values of MetLife's Ev To Sales and Dividend Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ev To Sales of MetLife are associated (or correlated) with its Dividend Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Dividend Yield has no effect on the direction of Ev To Sales i.e., MetLife's Ev To Sales and Dividend Yield go up and down completely randomly.

Correlation Coefficient

0.42

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Dividend Yield

Dividend Yield is MetLife dividend as a percentage of MetLife stock price. MetLife dividend yield is a measure of MetLife stock productivity, which can be interpreted as interest rate earned on an MetLife investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Most indicators from MetLife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetLife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Selling General Administrative is likely to drop to about 5.8 B in 2025. Discontinued Operations is likely to gain to about (843 M) in 2025

	2022	2023	2024	2025 (projected)
Gross Profit	69.9B	65.9B	75.8B	52.8B
Total Revenue	69.9B	66.4B	76.4B	52.8B

Gross Profit Total Revenue

MetLife fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Other Assets	Cash And Short Term Investments	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Other Liab	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Inventory
Common Stock Shares Outstanding		0.74	0.58	0.85	0.85	0.76	0.7	-0.19	-0.3	0.21	0.37	-0.5	0.97	0.71	0.06	-0.44	-0.22	-0.46	0.33	0.2	-0.21	0.22	0.51	0.16	0.38	0.68
Total Assets	0.74		0.77	0.46	0.45	0.77	0.38	0.49	0.35	0.02	0.7	-0.14	0.79	1.0	0.24	-0.85	0.17	-0.26	0.38	0.16	0.12	0.63	0.88	0.69	0.7	0.14
Short Long Term Debt Total	0.58	0.77		0.39	0.39	0.48	0.64	0.31	0.21	-0.15	0.17	0.02	0.64	0.78	0.58	-0.67	-0.05	-0.22	0.01	-0.02	0.58	0.6	0.88	0.49	0.17	0.13
Other Current Liab	0.85	0.46	0.39		1.0	0.47	0.75	-0.37	-0.49	0.39	0.15	-0.6	0.78	0.44	-0.1	-0.11	-0.42	-0.38	0.22	0.24	-0.24	0.1	0.25	-0.1	0.16	0.88
Total Current Liabilities	0.85	0.45	0.39	1.0		0.47	0.75	-0.37	-0.49	0.39	0.14	-0.6	0.78	0.44	-0.1	-0.11	-0.43	-0.38	0.22	0.24	-0.24	0.1	0.24	-0.1	0.16	0.88
Total Stockholder Equity	0.76	0.77	0.48	0.47	0.47		0.37	0.09	0.04	0.1	0.55	-0.61	0.84	0.71	0.15	-0.52	0.11	-0.65	0.27	-0.11	-0.27	0.12	0.59	0.33	0.55	0.43
Net Debt	0.7	0.38	0.64	0.75	0.75	0.37		-0.36	-0.57	0.09	-0.21	-0.46	0.65	0.37	0.31	-0.05	-0.62	-0.47	-0.12	-0.07	0.2	0.08	0.36	-0.19	-0.21	0.7
Retained Earnings	-0.19	0.49	0.31	-0.37	-0.37	0.09	-0.36		0.87	-0.07	0.56	0.42	-0.11	0.52	0.07	-0.63	0.6	0.3	0.23	0.08	0.42	0.63	0.57	0.85	0.53	-0.62
Cash	-0.3	0.35	0.21	-0.49	-0.49	0.04	-0.57	0.87		-0.17	0.53	0.45	-0.19	0.38	0.19	-0.59	0.68	0.28	0.1	-0.02	0.31	0.56	0.49	0.8	0.51	-0.67
Other Assets	0.21	0.02	-0.15	0.39	0.39	0.1	0.09	-0.07	-0.17		0.05	-0.4	0.18	0.01	-0.37	0.2	0.1	0.18	-0.04	-0.07	-0.29	-0.28	-0.2	-0.19	0.04	0.39
Cash And Short Term Investments	0.37	0.7	0.17	0.15	0.14	0.55	-0.21	0.56	0.53	0.05		-0.09	0.43	0.7	-0.09	-0.72	0.38	-0.16	0.43	0.17	-0.34	0.42	0.53	0.68	1.0	-0.11
Non Current Liabilities Total	-0.5	-0.14	0.02	-0.6	-0.6	-0.61	-0.46	0.42	0.45	-0.4	-0.09		-0.49	-0.08	0.07	-0.24	0.32	0.75	0.1	0.34	0.51	0.39	0.02	0.31	-0.09	-0.83
Other Stockholder Equity	0.97	0.79	0.64	0.78	0.78	0.84	0.65	-0.11	-0.19	0.18	0.43	-0.49		0.76	0.13	-0.56	-0.12	-0.52	0.29	0.11	-0.2	0.21	0.62	0.24	0.44	0.59
Total Liab	0.71	1.0	0.78	0.44	0.44	0.71	0.37	0.52	0.38	0.01	0.7	-0.08	0.76		0.24	-0.87	0.17	-0.21	0.38	0.19	0.16	0.68	0.89	0.71	0.7	0.1
Total Current Assets	0.06	0.24	0.58	-0.1	-0.1	0.15	0.31	0.07	0.19	-0.37	-0.09	0.07	0.13	0.24		-0.23	-0.31	-0.27	-0.66	-0.63	0.52	0.17	0.44	0.02	-0.1	-0.12
Short Term Debt	-0.44	-0.85	-0.67	-0.11	-0.11	-0.52	-0.05	-0.63	-0.59	0.2	-0.72	-0.24	-0.56	-0.87	-0.23		-0.41	0.06	-0.38	-0.22	-0.2	-0.65	-0.87	-0.83	-0.72	0.27
Other Liab	-0.22	0.17	-0.05	-0.42	-0.43	0.11	-0.62	0.6	0.68	0.1	0.38	0.32	-0.12	0.17	-0.31	-0.41		0.39	0.46	0.26	-0.03	0.25	0.19	0.6	0.37	-0.51
Accounts Payable	-0.46	-0.26	-0.22	-0.38	-0.38	-0.65	-0.47	0.3	0.28	0.18	-0.16	0.75	-0.52	-0.21	-0.27	0.06	0.39		0.2	0.45	0.3	0.27	-0.31	0.07	-0.16	-0.56
Non Current Assets Total	0.33	0.38	0.01	0.22	0.22	0.27	-0.12	0.23	0.1	-0.04	0.43	0.1	0.29	0.38	-0.66	-0.38	0.46	0.2		0.88	-0.26	0.44	0.15	0.46	0.45	0.02
Non Currrent Assets Other	0.2	0.16	-0.02	0.24	0.24	-0.11	-0.07	0.08	-0.02	-0.07	0.17	0.34	0.11	0.19	-0.63	-0.22	0.26	0.45	0.88		-0.1	0.47	-0.01	0.29	0.19	-0.01
Long Term Debt	-0.21	0.12	0.58	-0.24	-0.24	-0.27	0.2	0.42	0.31	-0.29	-0.34	0.51	-0.2	0.16	0.52	-0.2	-0.03	0.3	-0.26	-0.1		0.43	0.38	0.25	-0.36	-0.36
Net Receivables	0.22	0.63	0.6	0.1	0.1	0.12	0.08	0.63	0.56	-0.28	0.42	0.39	0.21	0.68	0.17	-0.65	0.25	0.27	0.44	0.47	0.43		0.64	0.74	0.42	-0.25
Good Will	0.51	0.88	0.88	0.25	0.24	0.59	0.36	0.57	0.49	-0.2	0.53	0.02	0.62	0.89	0.44	-0.87	0.19	-0.31	0.15	-0.01	0.38	0.64		0.77	0.52	-0.05
Common Stock Total Equity	0.16	0.69	0.49	-0.1	-0.1	0.33	-0.19	0.85	0.8	-0.19	0.68	0.31	0.24	0.71	0.02	-0.83	0.6	0.07	0.46	0.29	0.25	0.74	0.77		0.67	-0.4
Short Term Investments	0.38	0.7	0.17	0.16	0.16	0.55	-0.21	0.53	0.51	0.04	1.0	-0.09	0.44	0.7	-0.1	-0.72	0.37	-0.16	0.45	0.19	-0.36	0.42	0.52	0.67		-0.1
Inventory	0.68	0.14	0.13	0.88	0.88	0.43	0.7	-0.62	-0.67	0.39	-0.11	-0.83	0.59	0.1	-0.12	0.27	-0.51	-0.56	0.02	-0.01	-0.36	-0.25	-0.05	-0.4	-0.1

Click cells to compare fundamentals

MetLife Account Relationship Matchups

MetLife fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	913.2M	869.4M	808.9M	762.3M	876.6M	954.7M
Total Assets	795.1B	759.7B	666.6B	687.6B	790.7B	656.2B
Short Long Term Debt Total	18.1B	17.4B	18.0B	18.8B	21.7B	18.1B
Other Current Liab	(522M)	(525M)	(3.0B)	196M	176.4M	167.6M
Total Current Liabilities	393M	341M	217M	505M	454.5M	431.8M
Total Stockholder Equity	74.6B	67.5B	27.0B	30.0B	34.5B	46.4B
Net Debt	(1.6B)	(2.6B)	(2.2B)	(1.8B)	(1.6B)	(1.5B)
Retained Earnings	36.5B	41.2B	42.0B	40.1B	46.2B	24.7B
Cash	19.8B	20.0B	20.2B	20.6B	23.7B	12.6B
Other Assets	6.1B	(10.1B)	357.5B	(232.9B)	(209.6B)	(199.2B)
Cash And Short Term Investments	378.5B	367.5B	301.9B	302.1B	347.4B	188.3B
Liabilities And Stockholders Equity	795.1B	759.7B	666.6B	687.6B	790.7B	656.2B
Non Current Liabilities Total	28.8B	26.8B	639.1B	657.3B	755.9B	793.7B
Other Stockholder Equity	20.0B	15.4B	12.2B	9.1B	10.5B	19.7B
Total Liab	720.3B	692.0B	639.3B	657.3B	755.9B	609.5B
Total Current Assets	396.4B	384.8B	297.0B	302.1B	347.4B	286.7B
Accumulated Other Comprehensive Income	18.1B	10.9B	(27.1B)	(19.2B)	(17.3B)	(16.5B)
Short Term Debt	235M	393M	341M	119M	107.1M	101.7M
Other Liab	548.5B	663.5B	633.0B	512.5B	589.3B	618.8B
Accounts Payable	363M	129M	2.2B	20.8B	18.7B	19.7B
Non Current Assets Total	392.7B	385.0B	12.1B	618.5B	711.2B	746.8B
Non Currrent Assets Other	(392.7B)	(385.0B)	(309.3B)	450.6B	518.1B	544.0B
Long Term Debt	4.0B	17.1B	17.8B	18.7B	21.5B	13.0B
Net Receivables	17.9B	17.3B	17.4B	29.2B	33.5B	18.7B
Good Will	10.1B	9.5B	9.3B	9.2B	10.6B	7.7B
Short Term Investments	358.7B	347.5B	281.7B	287.5B	330.6B	190.6B
Inventory	(62.4B)	(59.9B)	(55.4B)	(104.3B)	(93.9B)	(89.2B)
Treasury Stock	(12.7B)	(13.8B)	(18.2B)	(21.5B)	(19.3B)	(18.3B)
Intangible Assets	18.7B	18.3B	25.5B	20.9B	24.1B	12.2B
Property Plant Equipment	2.8B	2.6B	2.2B	1.9B	2.1B	1.5B
Property Plant And Equipment Net	381.7B	375.3B	1.9B	(148.6B)	(170.9B)	(162.3B)
Other Current Assets	59.9B	55.4B	54.1B	69.1B	62.2B	100.9B
Noncontrolling Interest In Consolidated Entity	238M	259M	267M	247M	284.1M	303.9M
Retained Earnings Total Equity	33.1B	36.5B	41.2B	42.0B	48.2B	30.2B
Deferred Long Term Liab	9.1B	11.0B	9.7B	325M	373.8M	355.1M
Net Tangible Assets	56.8B	64.4B	57.9B	17.7B	16.0B	15.2B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for MetLife Stock Analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC